Wolfe Research on Regeneron Pharma (REGN): 'Results were good'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Regeneron (NASDAQ: REGN) | Delayed: 726.47 -8.73 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $735.20 | 52 Week High | $592.36 | |||
| Open | $734.36 | 52 Week Low | $325.35 | |||
| Day High | $736.42 | P/E | 190.67 | |||
| Day Low | $722.02 | EPS | $3.81 | |||
| Volume | 691,085 | |||||
